A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Implantable cardioverter defibrillator: decision-making on turning off in patients with end-stage heart failure
2020
Russian Journal of Cardiology
The use of implantable cardioverter defibrillators has become a common standard method of primary and secondary prevention of sudden cardiac death, prolonging the life of patients with cardiomyopathy. At the same time, with the disease and comorbidity progression, at the final stages of life, a difficult decision arises to turn off the device due to a shift in priorities from extending life to maintaining its quality. Heart failure patients eventually die due to the progression of the
doi:10.15829/1560-4071-2020-3868
doaj:1d43641f760c411fb5e70015e602d8df
fatcat:yqzabrdnzreevep4cit7zhtc4q